Beringea, a venture capital/private equity firm in Farmington Hills, said it has sold Steak Group to Dentsu for an undisclosed amount. Steak, a digital medial firm, employs 94 people in New York, London, and Melbourne, Australia.
Category: National
TechStars Seattle, on the Prowl for Talented Coders, Adopts HackStars Program
Last year, the organizers of TechStars in Boulder, CO, decided to try a little experiment. Already stocked with 10 teams of entrepreneurs working on their proto-companies, the startup boot-camp saw a niche for extra hands to help knock out some of the startups’ technical projects. So David Cohen, TechStars’ founder and CEO, brought in a … Continue reading “TechStars Seattle, on the Prowl for Talented Coders, Adopts HackStars Program”
Qualcomm Cuts Deal With Creative Artists; PowerGenix Targets Micro-Hybrid Market, Ferruolo Moves to USD Law School, & More San Diego BizTech News
The Memorial Day holiday made it a short week for high-tech news in San Diego. Here’s what you need to know from last week. —About 2,000 mobile app developers and others attended the two-day Uplinq conference hosted by San Diego-based Qualcomm (NASDAQ: [[ticker:QCOM]]), the world’s largest wireless chipmaker. A new partnership with Hollywood’s Creative Artists … Continue reading “Qualcomm Cuts Deal With Creative Artists; PowerGenix Targets Micro-Hybrid Market, Ferruolo Moves to USD Law School, & More San Diego BizTech News”
ACT Biotech, Scooping Up Bayer’s Cast-Off, Shows Promise With Stomach Cancer Drug
You know saying about one man’s loss being another man’s gain? That looks like the storyline that’s playing out at San Francisco-based ACT Biotech, which presented some promising results over the weekend with a new cancer drug it picked up off the scrap heap a few years ago from Germany-based Bayer (NYSE: [[ticker:BAY]]). ACT Biotech, … Continue reading “ACT Biotech, Scooping Up Bayer’s Cast-Off, Shows Promise With Stomach Cancer Drug”
Adaptive TCR, a Fred Hutch Spinoff, Snags $5.8M to Take Immune System Profiling Up a Notch
Seattle-based Adaptive TCR, a startup that grew out of immune-system profiling work at the Fred Hutchinson Cancer Research Center, has raised $5.8 million in an equity investment round that could be worth as much as $7.5 million over time. Adaptive TCR, profiled in these pages back in December, has secured the new financing from a … Continue reading “Adaptive TCR, a Fred Hutch Spinoff, Snags $5.8M to Take Immune System Profiling Up a Notch”
The Quest For Biotech Independence: Maybe It Isn’t So Quixotic After All
Conventional wisdom a couple years ago said that the era of the independent biotech giant was over. Nobody would ever again build a multi-billion dollar, fully integrated independent biopharma company on the scale of an Amgen (NASDAQ: [[ticker:AMGN]]), or even a Gilead Sciences (NASDAQ: [[ticker:GILD]]). Drug development is too risky, time-consuming, and expensive. Investors, tired … Continue reading “The Quest For Biotech Independence: Maybe It Isn’t So Quixotic After All”
Dear Apple: Go Big with Siri and Nuance in iOS 5
As someone who served on the boards of Siri and Nuance—two companies whose technologies are rumored to be deeply integrated into Apple’s upcoming iOS 5—I might have a unique take on what’s possible at the upcoming Apple World Wide Developer Conference (WWDC ) in San Francisco June 6-10. I throw my speculations into the ring … Continue reading “Dear Apple: Go Big with Siri and Nuance in iOS 5”
Reinventing the Board Meeting
[This post combines Part 1 and Part 2 of a series posted this week on Steve Blank’s blog.] As customer and agile development reinvent the Startup, it’s time to ask why startup board governance has not kept up with the pace of innovation. Board meetings that guide startups haven’t changed since the early 1900’s. It’s … Continue reading “Reinventing the Board Meeting”
The Next Boston-Area IPO, New Incubators, Unsung Heroes, and the Lost (& Found) Generation: 10 Tech Tidbits
As we enter the summer months, I wanted to give readers a quick look into my reporter’s notebook. I have been shifting into high gear with events and other things, but once the storm passes I’ll be writing more again. Meanwhile, I’m hearing tons of interesting stuff from the local startup and innovation community, some … Continue reading “The Next Boston-Area IPO, New Incubators, Unsung Heroes, and the Lost (& Found) Generation: 10 Tech Tidbits”
Gates Foundation Shows Off New Campus to Local Bigwigs: The Photo Gallery
Bill Gates reportedly spent a fair chunk of change, $500 million, on a new campus near the Seattle Center for his charitable foundation. So naturally, it was only a matter of time before the software mogul-turned-humanitarian and his wife Melinda decided to invite about 1,000 or so community leaders in media, politics, and business to … Continue reading “Gates Foundation Shows Off New Campus to Local Bigwigs: The Photo Gallery”
Orexigen, Facing High Hurdle at FDA, Puts Obesity Drug Development on Hold; Shares Tank
San Diego-based Orexigen Therapeutics has been smacked down hard by the FDA, and now the company has decided it’s time to throw up its hands and find something else to do. Orexigen (NASDAQ: [[ticker:OREX]]) said today it is putting on hold any further development of its obesity drug programs after getting what you’d have to … Continue reading “Orexigen, Facing High Hurdle at FDA, Puts Obesity Drug Development on Hold; Shares Tank”
Dinner Is On Eric Lefkofsky: Groupon Co-Founder and U-M Alum Pockets $300M+ From Stock Sales, More to Come From IPO
Word of advice to anyone who dines with Eric Lefkofsky: make sure he picks up the bill. Trust me folks, he can afford it. We always assumed the Groupon co-founder and University of Michigan alumnus would make a lot of money from the startup’s inevitable IPO. Sure enough, the online coupon site said Thursday that … Continue reading “Dinner Is On Eric Lefkofsky: Groupon Co-Founder and U-M Alum Pockets $300M+ From Stock Sales, More to Come From IPO”
Fourth Annual Internet Week a Panoply of Learning, Networking, and Celebrating for NYC’s Web Entrepreneurs
Internet Week New York kicks off June 6 with a menu of 200 events that chairman David-Michel Davies promises will be “incredibly diverse and all curated by the Internet community in NYC.” Internet Week was founded in 2008 as a public/private partnership by the International Academy of Digital Arts and Sciences and the City of … Continue reading “Fourth Annual Internet Week a Panoply of Learning, Networking, and Celebrating for NYC’s Web Entrepreneurs”
Silicon Chef: A Half-Baked Guide to Food Startups
[Updated 12/06/12 with additional listings] When the ex-CEO of Pure Digital, maker of the famous Flip pocket camcorder, wins funding from Sequoia Capital to open a chain of grilled cheese sandwich shops, it may be time to abandon your own enterprise-cloud-marketing-analytics-automation venture or your social-mobile-deals-gamification startup and think about getting into the food business. I was … Continue reading “Silicon Chef: A Half-Baked Guide to Food Startups”
Ariad and Infinity to Reveal Data at ASCO, Excelimmune Gets $10.5M, Hologic Buys TCT, & More Boston-Area Life Sciences News
You wouldn’t know we had a holiday this week, with the rate Boston life sciences companies are pumping out news. They’ve inked partnerships, announced fundings, made acquisitions, and are gearing up for a big medical convention this weekend. —Cambridge, MA-based Ariad Pharmaceuticals (NASDAQ: [[ticker:ARIA]]) will reveal data from a clinical trial of its drug ridaforolimus to … Continue reading “Ariad and Infinity to Reveal Data at ASCO, Excelimmune Gets $10.5M, Hologic Buys TCT, & More Boston-Area Life Sciences News”
Histogen Interprets Court Ruling as Victory in Patent Infringement Suit
San Diego-based Histogen, a four-year-old biomedical startup, claimed a key victory today after a federal judge issued a series of findings in a patent infringement case filed in 2009 against the company by a cross-town rival, Carlsbad, CA-based SkinMedica. Before the suit was filed, Histogen had plans to develop products derived from skin cells grown … Continue reading “Histogen Interprets Court Ruling as Victory in Patent Infringement Suit”
So Close They Can Taste It; NanoBio, Investors Eye Potential IPO
Is NanoBio heading towards an IPO? Probably way too early to make that call. But the Ann Arbor, MI-based drug startup and its investors are not exactly discouraging such talk. “I think the company has the potential to be a public company,” says George Arida, a managing director of Venture Investors. “It absolutely has the … Continue reading “So Close They Can Taste It; NanoBio, Investors Eye Potential IPO”
Join a Q&A with Tech Founders David Cancel, Joe Chung, Jules Pieri, and Ellen Rubin at XSITE 2011 on June 16
Founding a startup means facing so many hazards and unknowns that it can feel like establishing a new country. How are you going to encourage immigration to build up your population (i.e., customers)? How do you husband your natural resources (capital) and attract strong leaders (employees)? What if your constitution (your business plan) needs to … Continue reading “Join a Q&A with Tech Founders David Cancel, Joe Chung, Jules Pieri, and Ellen Rubin at XSITE 2011 on June 16”
Life Technologies’ Ion Machine Speeds Analyses of Deadly European Illness
Rapid genetic analysis made possible by Carlsbad, CA-based Life Technologies’ new semiconductor sequencing technology strongly suggests that the cause of a deadly foodborne outbreak sweeping Europe is an aggressive mutant type of two pathogenic E. coli strains. The illness has left 18 dead in Germany, where the outbreak is focused, and sickened thousands in nine … Continue reading “Life Technologies’ Ion Machine Speeds Analyses of Deadly European Illness”
Rock Health, A New Incubator for Healthcare IT Startups, Names Its First Class
The summer after her first year at Harvard Business School, Halle Tecco got an internship at Apple in Cupertino, CA, helping to evaluate mobile apps for the health and medical category of the iTunes App Store. “I was on the phone all day with big hospitals and healthcare organizations who didn’t put the love into … Continue reading “Rock Health, A New Incubator for Healthcare IT Startups, Names Its First Class”
NeuroHealing Repurposes Drugs, Resulting in Potential New Remedies For CNS Disorders
NeuroHealing Pharmaceuticals was founded in 2004 with an unusual mission and out-of-the-box business model. It scours the vast world of approved drugs for molecules that can be reformulated and then repositioned as therapies to treat diseases of the central nervous system. And it does so with only four full-time employees, because NeuroHealing is a “virtual” … Continue reading “NeuroHealing Repurposes Drugs, Resulting in Potential New Remedies For CNS Disorders”
Theravance, Glaxo Lung Drug Passes Two Pivotal Trials; Two More to Go
GlaxoSmithKline is counting on a new respiratory drug it is developing with South San Francisco-based Theravance, and today the companies got some good news about the treatment. Glaxo and Theravance (NASDAQ: [[ticker:THRX]]) said today that its once-daily inhaled corticosteroid combined with a long-acting beta agonist (Relovair) passed a pair of pivotal stage studies looking at … Continue reading “Theravance, Glaxo Lung Drug Passes Two Pivotal Trials; Two More to Go”
FDA Approves Optimer Antibiotic, Amylin Wins Legal Round Against Lilly, Investors Excited by Orexigen Move, & More San Diego Life Sciences News
The long Memorial Day weekend made for a short roundup of life sciences news this week. So we’ll be brief. —The FDA approved Optimer Pharmaceuticals‘ drug application for fidaxomicin (Dificid) as a new treatment for the nasty intestinal infection caused by the Clostridium difficile bacterium. Optimer says its treatment cures patients about 90 percent of … Continue reading “FDA Approves Optimer Antibiotic, Amylin Wins Legal Round Against Lilly, Investors Excited by Orexigen Move, & More San Diego Life Sciences News”
Facebook, Google & Beyond: Rand Fishkin of SEOmoz & Ben Elowitz of Wetpaint Debate the Future of Information and Relationships
Among the “Gang of Four” tech giants that Google Chairman Eric Schmidt says are driving consumer technology innovation, two iconic companies—Google and Facebook—are battling for an important title: Who will dominate the means of accessing, sorting, and connecting to the Internet’s flood of information. With Facebook on the rise, and Google’s self-professed stumbles in seizing … Continue reading “Facebook, Google & Beyond: Rand Fishkin of SEOmoz & Ben Elowitz of Wetpaint Debate the Future of Information and Relationships”
OneStop Singles, Small but Profitable, Flirts for Attention in Crowded Online Dating Industry
Standing out in New York can be a challenge for a young company—especially one serving the singles scene. The “been there, done that” attitude is difficult to overcome in Manhattan when pushing a dating website, given the plethora of paid and free services available such as Match.com, eHarmony, OkCupid, and PlentyofFish. While many dating services … Continue reading “OneStop Singles, Small but Profitable, Flirts for Attention in Crowded Online Dating Industry”
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company
Chris Garabedian took his first shot at being a CEO last December. Immediately, people thought this was a little bit crazy. Friends wondered, why leave a job as an up-and-coming VP of corporate strategy at a biotech powerhouse like Summit, NJ-based Celgene (NASDAQ: [[ticker:CELG]]) to run an obscure little company like AVI Biopharma (NASDAQ: [[ticker:AVII]])? … Continue reading “AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company”
Infinity Dares to Think Big Against Pancreatic Cancer, Prepares to Show Early Results This Weekend
Infinity Pharmaceuticals’ top execs sometimes get strange looks when they say they are developing a new drug for pancreatic cancer. This, after all, is a wicked malignancy that usually kills patients in just a few months, and has dashed the hopes of many cancer drug developers over the years. Yet Cambridge, MA-based Infinity (NASDAQ: [[ticker:INFI]]) … Continue reading “Infinity Dares to Think Big Against Pancreatic Cancer, Prepares to Show Early Results This Weekend”
An Investor’s Observations on Investing and Company Building in an Emerging Market: India
As a technology venture capitalist, I provide funds to help companies reach their next evolutionary level more quickly, efficiently, and successfully than without my cash. My mandate is to also offer non-cash benefit and support that, one might argue, is even more critical than cash to speed ahead of milestones, competitors, and expectations. In the … Continue reading “An Investor’s Observations on Investing and Company Building in an Emerging Market: India”
LED Lighting And Video Game Pioneer Peter Hochstein Dies At Age 65
Relume Technologies founder Peter Hochstein, a pioneer in LED outdoor lighting and multi-player video game technology, unexpectedly died of natural causes over Memorial Day weekend. He was 65 years old. Hochstein, who served as Relume’s president, board director, and chief technology officer, passed away at his home in Troy, MI, Relume said in a statement. … Continue reading “LED Lighting And Video Game Pioneer Peter Hochstein Dies At Age 65”
Qualcomm Going Hollywood in Bid to Expand Mobile Content
Qualcomm (NASDAQ: [[ticker:QCOM]]), lifted the curtain today on a new partnership with Hollywood’s powerful Creative Artists Agency, setting the stage for a new generation of mobile apps that can take advantage of CAA’s portfolio of movie stars, athletes, musicians, and video games. Qualcomm chairman and CEO Paul Jacobs revealed the new partnership today at Uplinq, … Continue reading “Qualcomm Going Hollywood in Bid to Expand Mobile Content”
With California Deals Heating Up, Polaris Venture Partners to Open Palo Alto Office
Polaris Venture Partners is significantly increasing its presence in California, where roughly one-third of its active portfolio companies are now based, and plans to soon open an office in Palo Alto, in the heart of Silicon Valley, Xconomy has learned. Polaris general partner Dave Barrett says the firm is still looking at space and so … Continue reading “With California Deals Heating Up, Polaris Venture Partners to Open Palo Alto Office”
Today’s XSITEing Opportunity: Galaxy Tab 10.1 Giveaway
As if there weren’t already enough reasons to be looking forward to the June 16 Xconomy Summit on Innovation, Technology, and Entrepreneurship, today we’re adding a thin, shiny reason with HD video and front and rear cameras. We’re going to throw the names of the first 50 folks to register in June for XSITE 2011 into … Continue reading “Today’s XSITEing Opportunity: Galaxy Tab 10.1 Giveaway”
Tippr Grabs Sales & Tech Talent in DealPop Acquisition, Continuing Daily Deals Dogfight for Third Place
[Updated at 11:40 am with Groupon/Expedia news] When was the last time a contest for third place was so action-packed? Riding the skyrocketing valuations of online coupon dealers Groupon and Living Social, startups like Seattle’s Tippr and New York-based BuyWithMe have been engaging in some hand-to-hand combat for growth. Today, Tippr makes another move with … Continue reading “Tippr Grabs Sales & Tech Talent in DealPop Acquisition, Continuing Daily Deals Dogfight for Third Place”
Somaxon Fighting Fresh Challenge from Generic Drug-Makers
San Diego’s Somaxon Pharmaceuticals, which overcame setbacks before winning FDA approval for its insomnia drug last year, is now facing some stiff new challenges, according to an interesting story by Keith Darcé of The San Diego Union-Tribune. As we explained last year, Somaxon already was facing stiff competition from over-the-counter sleeping aids and other generics … Continue reading “Somaxon Fighting Fresh Challenge from Generic Drug-Makers”
Convore, Rebooting IRC, Brings Group Chat Into the Social Media Era
Eighth in a series of profiles of Y Combinator Winter 2011 startups. In an article last year called “10 Old Tech Ideas That Are New Again,” my colleague Greg Huang listed concepts such as group-buying sites and e-book readers that had their first tentative flowering back in the dot-com era or earlier and are now making … Continue reading “Convore, Rebooting IRC, Brings Group Chat Into the Social Media Era”
San Diego’s PowerGenix Engineers a New Strategy for Nickel-Zinc Battery
Dan Squiller concedes that the rechargeable lithium-ion battery has become the dominant power source for electricity-hungry technologies that include everything from laptop computers to electric vehicles. But he contends lithium-ion batteries have some drawbacks too—they’re expensive, potentially flammable, and difficult to recycle. As the CEO at San Diego’s PowerGenix, Squiller also maintains that there is … Continue reading “San Diego’s PowerGenix Engineers a New Strategy for Nickel-Zinc Battery”
New York Area Companies Head to ASCO With High Hopes For Future Cancer Blockbusters
[Corrected 6/3/11, 7 a.m. See below.] This weekend, the pharmaceutical industry will descend on Chicago for the annual meeting of the American Society of Clinical Oncology (ASCO). The show provides an opportunity for drug companies to impress physicians and investors with data on cancer drugs they’re developing, as well as those that are already on the … Continue reading “New York Area Companies Head to ASCO With High Hopes For Future Cancer Blockbusters”
Trinity Leads $10M Investment in Act-On Software, Helping Oregon-Based Digital Marketing Company Fuel International Growth
[Updated 4:45 pm to correct headline, copy reflecting Trinity as lead investor. Previous information provided by company spokesperson was incorrect.] Well, that was quick. Act-On Software, a Beaverton, OR-based online marketing company, has raised a $10 million financing round led by Trinity Ventures at what founder and CEO Raghu Raghavan calls “a substantial step up in … Continue reading “Trinity Leads $10M Investment in Act-On Software, Helping Oregon-Based Digital Marketing Company Fuel International Growth”
Dossia Partners With Health Language To Offer Electronic Medical Records in Plain English
The non-profit consortium Dossia has branded itself as a provider of digital health records focused on ease of use for the consumer. The organization got started in 2006 to offer the Web-based records to employees at its member companies—like BP America, Intel, Pitney Bowes, and Wal-Mart—and has racked up plenty of data on patients’ doctors … Continue reading “Dossia Partners With Health Language To Offer Electronic Medical Records in Plain English”
Excelimmune Grabs $10.5M, Aveo Gets $15M In J&J Deal, Myriant Aims for $125M IPO, & More Boston-Area Deals News
Boston tech and life sciences companies kept busy even through the holiday weekend with partnership, IPO, and financing news. —Proteostasis Therapeutics of Cambridge, MA, received an initial payment of $20 million from Elan to develop traditional small molecule drugs and diagnostics against neurodegenerative diseases like Parkinson’s, Huntington’s, and multiple sclerosis. The partnership could also include … Continue reading “Excelimmune Grabs $10.5M, Aveo Gets $15M In J&J Deal, Myriant Aims for $125M IPO, & More Boston-Area Deals News”
Heroku, Solazyme, Sparkbuy: The 1-Minute Version of Last Week’s Bay Area BizTech News
Cloud computing was my big theme last week, but we also covered stories about renewable energy, and we brought back a report from the future (the way the Churchill Club sees it, anyway). —I profiled Heroku, the Y Combinator-backed Ruby on Rails platform that was acquired by Salesforce.com last December for $212 million. Co-founder Adam … Continue reading “Heroku, Solazyme, Sparkbuy: The 1-Minute Version of Last Week’s Bay Area BizTech News”
Cleantech Startup Vestaron Raises $445,000 in Series B Financing
Vestaron has raised about $445,000 from the sale of equity, according to SEC documents. Overall, the startup, based in Kalamazoo, MI, is seeking $8 million, the filing says. So far, Vestaron has raised $9 million from investors including Open Prairie Ventures, the Southwest Michigan Life Science Venture Fund, and the Michigan Strategic Fund. These investors … Continue reading “Cleantech Startup Vestaron Raises $445,000 in Series B Financing”
Calling All Startups: We Want You to Speak at XSITE on June 16 (If You Are The One)
OK, let’s cut to the chase here. We’re looking for The One. One more cool, young startup that could change the world. We’ve got 11 confirmed. We want an even dozen. Do you have what it takes? The setting: It’s our third annual flagship conference, XSITE, at Babson College on June 16, and the startup … Continue reading “Calling All Startups: We Want You to Speak at XSITE on June 16 (If You Are The One)”
Xconomy Not Going Public, But We Had a Great Time at NYSE Euronext—Thanks to Our New York Supporters
Xconomy held a great party last Thursday on the floor of the New York Stock Exchange. The only caveats from our fantastic host NYSE Euronext was that if I rang the bell, the symbol XCON would never trade…(well, they didn’t actually say that, but I felt the hint was there). So we didn’t ring any … Continue reading “Xconomy Not Going Public, But We Had a Great Time at NYSE Euronext—Thanks to Our New York Supporters”
Tune In, Turn On, Drop Out—The Startup Genome Project
In April 2010 I received an email that said, “I’m an incoming Stanford student in the fall and working on a project that a number of people suggested I get in touch with you about.” Ok, I get a lot of these. Is this some grad student or post doc who wanted to do some … Continue reading “Tune In, Turn On, Drop Out—The Startup Genome Project”
Active Network Shares Rise, Accelrys Buys Sweden’s Contur, Mitek Raises $15M, & More San Diego BizTech News
The IPO market is clearly improving, with San Diego’s Active Network serving as the latest example in a slew of new stock offerings. We have that and all the other tech news you need to start your week. —Shares of the Active Network (NYSE: [[ticker:ACTV]]) steadily gained altitude last week after the San Diego-based provider … Continue reading “Active Network Shares Rise, Accelrys Buys Sweden’s Contur, Mitek Raises $15M, & More San Diego BizTech News”
Cyclacel Looks to ASCO as Showcase for Potent Cancer-Fighting Cocktail
For most Big Pharma companies, the annual meeting of the American Society of Clinical Oncology (ASCO) is one of dozens of important venues for spotlighting data on experimental drugs. But for tiny Cyclacel Pharmaceuticals (NASDAQ: [[ticker:CYCC]])—which is focused on developing cancer treatments—the confab of oncologists, cancer researchers, and drugmakers is the make-or-break event of the … Continue reading “Cyclacel Looks to ASCO as Showcase for Potent Cancer-Fighting Cocktail”
With xoJane Launch, Say Media Embarks on Transformation into a “Passion-Based Media Company”
When VideoEgg bought its San Francisco neighbor Six Apart last fall and renamed the combined company Say Media, the reaction from many media watchers was, “Say what?” It wasn’t clear why a rich-media advertising network needed to own a blogging company, or what plans it had for Moveable Type and Typepad, Six Apart’s once-pioneering publishing … Continue reading “With xoJane Launch, Say Media Embarks on Transformation into a “Passion-Based Media Company””
Grubwithus Hits Boston On Its Quest To Bring Group Meals for Strangers to 30 Cities This Year
Seventh in a series of profiles of Y Combinator Winter 2011 startups. Grubwithus, a group-buying-meets-online-dating startup out of Y Combinator, is hitting Boston this week. The startup is introducing its group meals for strangers service in the city on June 1st. Similar to Groupon, Chicago-based Grubwithus works with restaurants to offer its users discounted meals. Unlike … Continue reading “Grubwithus Hits Boston On Its Quest To Bring Group Meals for Strangers to 30 Cities This Year”
Ariad Eagerly Awaits the Big Show, ASCO, To Display Cancer Trial Results
Ariad Pharmaceuticals’ stock has surged 73 percent since New Year’s Day, so you could say CEO Harvey Berger is having a better-than-average year. The Cambridge, MA-based cancer drug developer has seen its market valuation eclipse $1 billion, on a wave of anticipation heading into what could be the most important medical meeting in his company’s … Continue reading “Ariad Eagerly Awaits the Big Show, ASCO, To Display Cancer Trial Results”